TRIUMPH-1 Phase 3 Trial Results (May 2026) On May 21, 2026, Eli Lilly announced topline results from TRIUMPH-1, the pivotal Phase 3 obesity trial for retatrutide
Even the pharmaceutical advertising, with images of healthy people living active lives, uses nearly identical visual language for both drug classes
It works by stimulating insulin secretion, slowing gastric emptying, and reducing appetite, which also promotes weight loss
These can include: Burping was reported in the STEP 5 clinical trial and although the sulphur smell wasnt specifically measured, it likely relates to the way Wegovy slows digestion
If you catch it before injecting Good news
Dysplastic nevi of the scalp and forehead in children